glp-1 ads Serena Williams weight loss ad GLP-1 Weight Loss Medication |

About the author Dr Tim Hardman is the Founder and Managing Director of Niche Science & Technology Ltd., the UK-based CRO he established in 1998 to deliver tailored, science-driven support to pharmaceutical and biotech companies

While all of these approved therapies, including liraglutide, are successful at producing initial weight loss, each is limited in the magnitude, and for some, the duration of efficacy 21,40,54,55

Rare Vision Events (NAION) Rare vision complications, including non-arteritic anterior ischemic optic neuropathy (NAION), have been reported in post-marketing data

Second, call the member-services number on your card and ask three specific questions: Is covered for weight loss on my plan?, Whats the prior-authorization criteria?, and Whats my expected copay or coinsurance after PA? Get the case number

doi:10.1007/s12325-019-00914-9 40